Financhill
Sell
18

NPCE Quote, Financials, Valuation and Earnings

Last price:
$9.52
Seasonality move :
6.85%
Day range:
$9.50 - $10.27
52-week range:
$5.45 - $18.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.38x
P/B ratio:
12.87x
Volume:
232.6K
Avg. volume:
373.6K
1-year change:
28.48%
Market cap:
$312.2M
Revenue:
$79.9M
EPS (TTM):
-$0.84

Analysts' Opinion

  • Consensus Rating
    NeuroPace has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $17.13, NeuroPace has an estimated upside of 79.89% from its current price of $9.52.
  • Price Target Downside
    According to analysts, the lowest downside price target is $15.00 representing 100% downside risk from its current price of $9.52.

Fair Value

  • According to the consensus of 6 analysts, NeuroPace has 79.89% upside to fair value with a price target of $17.13 per share.

NPCE vs. S&P 500

  • Over the past 5 trading days, NeuroPace has underperformed the S&P 500 by -8.09% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • NeuroPace does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • NeuroPace has grown year-over-year revenues for 11 quarters straight. In the most recent quarter NeuroPace reported revenues of $22.5M.

Earnings Growth

  • NeuroPace has grown year-over-year earnings for 0 quarters straight. In the most recent quarter NeuroPace reported earnings per share of -$0.21.
Enterprise value:
305.8M
EV / Invested capital:
--
Price / LTM sales:
3.38x
EV / EBIT:
--
EV / Revenue:
3.63x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-16.85x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$63.1M
Return On Assets:
-25.09%
Net Income Margin (TTM):
-29.42%
Return On Equity:
-186.98%
Return On Invested Capital:
-34.26%
Operating Margin:
-22.85%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $48.6M $69.1M $84.3M $18.1M $22.5M
Gross Profit $34.6M $51.1M $63.1M $13.3M $17.3M
Operating Income -$39.4M -$26.4M -$19.3M -$7.5M -$5.1M
EBITDA -$35.7M -$21.1M -$14.3M -$6.2M -$4M
Diluted EPS -$1.86 -$1.18 -$0.84 -$0.32 -$0.21
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $47.1M $122.4M $90.2M $84.3M $97.5M
Total Assets $50.3M $129M $106.3M $98.9M $110.2M
Current Liabilities $10.8M $12.1M $9.9M $13.1M $14.7M
Total Liabilities $206.8M $66.2M $78.8M $84.5M $85.9M
Total Equity -$156.4M $62.8M $27.5M $14.3M $24.3M
Total Debt $53.2M $50.1M $53.9M $58M $59.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$35.2M -$17.5M -$17.9M -$7.5M -$7.5M
Cash From Investing $34.2M $15.4M $6.6M $2.4M -$37K
Cash From Financing $234K $8.5M $25.4M $72K $21.1M
Free Cash Flow -$35.6M -$17.7M -$18.1M -$7.6M -$7.5M
NPCE
Sector
Market Cap
$312.2M
$33.5M
Price % of 52-Week High
50.17%
48.01%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.97%
1-Year Price Total Return
28.48%
-33.61%
Beta (5-Year)
--
0.621
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $10.21
200-day SMA
Sell
Level $10.99
Bollinger Bands (100)
Sell
Level 10.35 - 14.07
Chaikin Money Flow
Sell
Level -238.7K
20-day SMA
Sell
Level $10.58
Relative Strength Index (RSI14)
Sell
Level 31.19
ADX Line
Sell
Level 4.6
Williams %R
Buy
Level -99.0148
50-day SMA
Sell
Level $12.56
MACD (12, 26)
Buy
Level 2.21
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Sell
Level -66.7K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-4.4737)
Sell
CA Score (Annual)
Level (-2.6176)
Buy
Beneish M-Score (Annual)
Level (-2.9629)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (4.4249)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Stock Forecast FAQ

In the current month, NPCE has received 6 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NPCE average analyst price target in the past 3 months is $17.13.

  • Where Will NeuroPace Stock Be In 1 Year?

    According to analysts, the consensus estimate is that NeuroPace share price will rise to $17.13 per share over the next 12 months.

  • What Do Analysts Say About NeuroPace?

    Analysts are divided on their view about NeuroPace share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NeuroPace is a Sell and believe this share price will drop from its current level to $15.00.

  • What Is NeuroPace's Price Target?

    The price target for NeuroPace over the next 1-year time period is forecast to be $17.13 according to 6 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is NPCE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for NeuroPace is a Buy. 6 of 6 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of NPCE?

    You can purchase shares of NeuroPace via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NeuroPace shares.

  • What Is The NeuroPace Share Price Today?

    NeuroPace was last trading at $9.52 per share. This represents the most recent stock quote for NeuroPace. Yesterday, NeuroPace closed at $9.52 per share.

  • How To Buy NeuroPace Stock Online?

    In order to purchase NeuroPace stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock